• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Refractory dysmyelopoietic anemia and acute leukemia.

作者信息

Rosenthal D S, Moloney W C

出版信息

Blood. 1984 Feb;63(2):314-8.

PMID:6692037
Abstract

One hundred and seventeen consecutive patients with refractory dysmyelopoietic anemia (RDA) were followed and studied over 6 yr. All RDA cases had at least two marrow cell lines involved with dysplasia and usually all three. Morphologically, the series could be divided into 55 cases that had primarily "erythroid" hyperplasia and 62 cases with primarily "myeloid" dysplasia. There was a significantly higher number of acute leukemias in the myeloid group, 21/62 (33.9%), than in the erythroid group, 7/55 (12.7%). Of the 117 cases, 64 had marrow culture studies performed using implanted diffusion chambers (DC) in an irradiated rat host. There was a highly statistically significant correlation between the development of leukemia and abnormal growth in DC during the RDA stage.

摘要

相似文献

1
Refractory dysmyelopoietic anemia and acute leukemia.
Blood. 1984 Feb;63(2):314-8.
2
[Aplastic anemia-a preleukemic stage (author's transl)].
Klin Wochenschr. 1975 Jun 15;53(12):581-3. doi: 10.1007/BF01468904.
3
Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.获得性再生障碍性贫血中发育异常改变的临床影响:儿童和成人骨髓活检的系统研究。
Ann Diagn Pathol. 2020 Apr;45:151459. doi: 10.1016/j.anndiagpath.2019.151459. Epub 2019 Dec 30.
4
Clinical contribution to the knowledge of hemopoietic dysplasias: long-term follow-up of 13 patients with refractory anemia.对造血发育异常认识的临床贡献:13例难治性贫血患者的长期随访
Acta Haematol. 1978;60(1):10-20. doi: 10.1159/000207690.
5
Adult leukemia developing after aplastic anemia: report of 8 cases.再生障碍性贫血后发生的成人白血病:8例报告。
Acta Haematol. 1988;79(3):174-7. doi: 10.1159/000205752.
6
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies.骨髓生成异常综合征:序贯临床及细胞遗传学研究
Blood. 1980 Apr;55(4):636-44.
7
Cytogenetic findings in the dysmyelopoietic syndrome.
Cancer. 1982 Dec 15;50(12):2834-8. doi: 10.1002/1097-0142(19821215)50:12<2834::aid-cncr2820501224>3.0.co;2-h.
8
Remission of acute myelogenous leukemia in elderly patients with prior refractory dysmyelopoietic anemia.既往难治性骨髓发育异常性贫血老年患者急性髓性白血病的缓解
Cancer. 1983 Sep 15;52(6):967-70. doi: 10.1002/1097-0142(19830915)52:6<967::aid-cncr2820520605>3.0.co;2-y.
9
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.再生障碍性贫血治疗后发生的恶性肿瘤。欧洲骨髓移植-重型再生障碍性贫血工作组。
N Engl J Med. 1993 Oct 14;329(16):1152-7. doi: 10.1056/NEJM199310143291603.
10
[Refractory anemia with hypercellular bone marrow and preleukemia (author's transl)].
Med Klin. 1976 Nov 26;71(48):2127-35.

引用本文的文献

1
Erythrocyte ferritin concentration in patients with myelodysplastic syndromes.骨髓增生异常综合征患者的红细胞铁蛋白浓度
J Clin Pathol. 1985 Jan;38(1):113-4. doi: 10.1136/jcp.38.1.113.
2
Refractory anaemia terminating in a combined lymphoproliferative and myeloproliferative disorder.难治性贫血最终发展为淋巴增殖性和骨髓增殖性联合疾病。
J Clin Pathol. 1985 Mar;38(3):297-300. doi: 10.1136/jcp.38.3.297.
3
Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.难治性血细胞减少症:根据骨髓细胞学和细胞计数的临床病程
Blut. 1987 Mar;54(3):153-63. doi: 10.1007/BF00320369.
4
Primary myelodysplastic syndrome with complex chromosomal rearrangements in a patient with Klinefelter's syndrome.
J Med Genet. 1986 Apr;23(2):183-5. doi: 10.1136/jmg.23.2.183.
5
Refractory myelodysplastic anaemias with hypocellular bone marrow.骨髓细胞减少的难治性骨髓增生异常综合征贫血
J Clin Pathol. 1988 Jul;41(7):763-7. doi: 10.1136/jcp.41.7.763.
6
Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.骨髓增生异常综合征:发病机制、功能异常及临床意义。
J Clin Pathol. 1985 Nov;38(11):1201-17. doi: 10.1136/jcp.38.11.1201.
7
Amsacrine, cytarabine and etoposide in the treatment of bad prognosis acute myeloid leukemia.安吖啶、阿糖胞苷和依托泊苷治疗预后不良的急性髓系白血病
Med Oncol Tumor Pharmacother. 1989;6(3):199-205. doi: 10.1007/BF02985191.
8
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group.低剂量阿糖胞苷(LD-AraC)联合粒细胞-巨噬细胞集落刺激因子(rh GM-CSF)治疗骨髓增生异常综合征(MDS)及高白血病风险患者。欧洲癌症研究与治疗组织白血病研究组。
Infection. 1992;20 Suppl 2:S116-23. doi: 10.1007/BF01705030.